Source: Annual Congress 2011 - Smoking-related diseases and smoking cessation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. J. Willke, D. Getsios, J. P. Marton, N. Revankar, K. H. Zou, J. Xenakis (New York, Lexington, United States Of America). Predicted impact of access to varenicline on abstinence simulating multiple quit attempts over smokers‘ lifetimes. Eur Respir J 2011; 38: Suppl. 55, 1796

Member's Comments

No comment yet.

Related content which might interest you: Predicted health and economic benefits of smoking cessation incorporating multiple quit attempts over a lifetime Source: Annual Congress 2011 - Smoking cessation science Year: 2011 Repeated antismoking counseling increases quit rate: relation to motivation and nicotine dependence Source: Eur Respir J 2005; 26: Suppl. 49, 489s Year: 2005 Improvement of quit smoking rate by combining varenicline and nicotine replacement therapy Source: Annual Congress 2009 - Smoking cessation Year: 2009 Couples of significant others (COSO) in a joint effort to quit smoking are more successful in achieving and maintaining abstinence Source: Annual Congress 2012 - Tobacco cessation Year: 2012 Most users quit e-cigarettes without succeeding to quit smoking Source: Virtual Congress 2021 – Tobacco and nicotine research during the pandemic Year: 2021 The cost-effectiveness of smoking cessation interventions. Accounting for medical costs in longer life expectancies Source: Annual Congress 2006 - How to treat tobacco smokers Year: 2006 Evaluation of the relationship between intention to quit and not smoking at home Source: Annual Congress 2012 - Tobacco comorbidity Year: 2012 The success rate of a smoking cessation programme in patients attempted to quit smoking Source: Eur Respir J 2002; 20: Suppl. 38, 133s Year: 2002 Causes of quitting treatment with varenicline in a smoking cessation clinic Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009 Are electronic cigarettes the real solution to quit smoking? Source: Virtual Congress 2021 – CCC Interstitial lung diseases Year: 2021 Effect of local program to quit smoking Source: Eur Respir J 2005; 26: Suppl. 49, 391s Year: 2005 The comparative effectiveness of smoking cessation drugs on prolonged abstinence – a network meta-analysis Source: Annual Congress 2009 - Smoking cessation Year: 2009 Electronic cigarettes for smoking cessation: an opportunity to readdress smoking cessation treatment Source: Eur Respir J, 56 (4) 2000098; 10.1183/13993003.00098-2020 Year: 2020 Clinical and pathological determinants of abstinence rate in smoking cessation with varenicline Source: Annual Congress 2010 - Smoking cessation interventions Year: 2010 Harmful effects of smoking: are they adequate reasoning for smokers to quit it? Source: Annual Congress 2009 - Smoking cessation Year: 2009 Comparison of efficiacy and success of hypnotherapy and medical drugs to quit smoking. First 6 months results Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009 Occurrence, health impact and motivation to quit smoking among young people and effectiveness of tobacco control programs Source: Annual Congress 2012 - Tobacco and shisha exposure in children and adolescents Year: 2012 The cost of smoking as a reason to quit: results from an open survey Source: Eur Respir J 2004; 24: Suppl. 48, 155s Year: 2004 The respiratory health benefits of quitting cannabis use Source: Eur Respir J 2015; 46: 1-4 Year: 2015